Detalhe da pesquisa
1.
TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2+ breast cancer.
Arch Toxicol
; 98(3): 865-881, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212449
2.
GATA3 mediates doxorubicin resistance by inhibiting CYB5R2-catalyzed iron reduction in breast cancer cells.
Drug Resist Updat
; 69: 100974, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230023
3.
Integrative analyses of scRNA-seq and scATAC-seq reveal CXCL14 as a key regulator of lymph node metastasis in breast cancer.
Hum Mol Genet
; 30(5): 370-380, 2021 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33564857
4.
Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages.
Cancer Cell Int
; 23(1): 137, 2023 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452413
5.
Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis.
Genet Res (Camb)
; 2023: 6782732, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36688087
6.
CBX3 promotes breast cancer progression and high level of CBX3 predicts poor prognosis in patients.
Neoplasma
; 70(1): 71-81, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36620876
7.
PHF20 is a Novel Prognostic Biomarker and Correlated with Immune Status in Breast Cancer.
Biochem Genet
; 61(4): 1369-1386, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36598702
8.
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial.
BMC Med
; 20(1): 498, 2022 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575513
9.
M2 Macrophage-Derived Exosomes Facilitate HCC Metastasis by Transferring αM ß2 Integrin to Tumor Cells.
Hepatology
; 73(4): 1365-1380, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594528
10.
Potential values of circulating tumor cell for detection of recurrence in patients of thyroid cancer: a diagnostic meta-analysis.
BMC Cancer
; 22(1): 954, 2022 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36064384
11.
Endoplasmic reticulum stress targeted therapy for breast cancer.
Cell Commun Signal
; 20(1): 174, 2022 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36345017
12.
Effect of statins use on risk and prognosis of breast cancer: a meta-analysis.
Anticancer Drugs
; 33(1): e507-e518, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407042
13.
Hyperthermia promotes exosome secretion by regulating Rab7b while increasing drug sensitivity in adriamycin-resistant breast cancer.
Int J Hyperthermia
; 39(1): 246-257, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35100921
14.
Circulating metabolites serve as diagnostic biomarkers for HER2-positive breast cancer and have predictive value for trastuzumab therapy outcomes.
J Clin Lab Anal
; 36(2): e24212, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34994982
15.
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China.
Chin J Cancer Res
; 34(6): 592-600, 2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36714346
16.
The role of long non-coding RNAs in drug resistance of cancer.
Clin Genet
; 99(1): 84-92, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583420
17.
MiR-145 in cancer therapy resistance and sensitivity: A comprehensive review.
Cancer Sci
; 111(9): 3122-3131, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32506767
18.
MiR-539 inhibits the malignant behavior of breast cancer cells by targeting SP1.
Biochem Cell Biol
; 98(3): 426-433, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31742423
19.
Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals.
Oncologist
; 25(10): e1473-e1480, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333626
20.
RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression.
Cell Commun Signal
; 18(1): 128, 2020 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32807176